{"filing":{"accession_number":"0001193125-26-323731","cik":"0000860730","ticker":"HCA","company_name":"HCA Healthcare, Inc.","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"d315311d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526323731/d315311d8k.htm"},"events":[{"id":21625,"run_id":19508,"accession_number":"0001193125-26-323731","anchor_item_number":"2.03","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"HCA Healthcare increased the size of its commercial paper program from $4.0 billion to $8.0 billion outstanding at any time, representing a material expansion of the issuer's direct financial obligations and borrowing capacity.","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21311,"accession_number":"0001193125-26-323731","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 is the dedicated disclosure item for creation of direct financial obligations, typically debt issuances, credit facilities, or term loans. The filing references Item 8.01 for details, which is standard practice when the substantive disclosure appears elsewhere in the 8-K. For a large healthcare operator like HCA Healthcare, debt issuance is material to investors assessing capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:15:41.778497+00:00","company_name":"","ticker":null,"filing_date":""},{"id":21312,"accession_number":"0001193125-26-323731","item_number":"8.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"HCA Inc. increased the size of its commercial paper program from $4.0 billion to $8.0 billion outstanding at any time on July 29, 2026. This represents a material expansion of the issuer's direct financial obligations and borrowing capacity, constituting a modification of an existing credit facility. While the commercial paper program itself was previously established, the doubling of its maximum aggregate principal amount is a material amendment that increases the registrant's debt-issuance capacity and should be disclosed under Item 8.01 as a material event affecting the company's financial structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:15:41.778497+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21311,"accession_number":"0001193125-26-323731","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 is the dedicated disclosure item for creation of direct financial obligations, typically debt issuances, credit facilities, or term loans. The filing references Item 8.01 for details, which is standard practice when the substantive disclosure appears elsewhere in the 8-K. For a large healthcare operator like HCA Healthcare, debt issuance is material to investors assessing capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:15:41.778497+00:00","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-29"},{"id":21312,"accession_number":"0001193125-26-323731","item_number":"8.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"HCA Inc. increased the size of its commercial paper program from $4.0 billion to $8.0 billion outstanding at any time on July 29, 2026. This represents a material expansion of the issuer's direct financial obligations and borrowing capacity, constituting a modification of an existing credit facility. While the commercial paper program itself was previously established, the doubling of its maximum aggregate principal amount is a material amendment that increases the registrant's debt-issuance capacity and should be disclosed under Item 8.01 as a material event affecting the company's financial structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:15:41.778497+00:00","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-07-29"}]}